Tyra Biosciences, Inc.

Direct answer

Tyra Biosciences, Inc. is publicly traded on NASDAQ under the ticker TYRA.

Tyra Biosciences, Inc. is a preclinical biopharmaceutical company focused on innovating treatments to tackle tumor resistance and enhance patient outcomes in oncology. Its flagship product candidate, TYRA-300, is a highly selective inhibitor of fibroblast growth factor receptor (FGFR)3, specifically engineered for the treatment of muscle-invasive bladder cancer. Beyond this, the company is advancing a pipeline of...

Can you invest in Tyra Biosciences, Inc.?

Yes. Tyra Biosciences, Inc. is publicly traded on NASDAQ under the ticker TYRA.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Tyra Biosciences, Inc.

Detailed equity research is provided by MarketSnap.